Nothing Special   »   [go: up one dir, main page]

ATE177111T1 - Doppelbindungs-isomer von equilin erhalten durch säure-isomerisierung - Google Patents

Doppelbindungs-isomer von equilin erhalten durch säure-isomerisierung

Info

Publication number
ATE177111T1
ATE177111T1 AT95915579T AT95915579T ATE177111T1 AT E177111 T1 ATE177111 T1 AT E177111T1 AT 95915579 T AT95915579 T AT 95915579T AT 95915579 T AT95915579 T AT 95915579T AT E177111 T1 ATE177111 T1 AT E177111T1
Authority
AT
Austria
Prior art keywords
equiline
double bond
bond isomers
acid isomerization
isoestrone
Prior art date
Application number
AT95915579T
Other languages
English (en)
Inventor
Frederick Quincy Gemmill Jr
Chester Eugene Orzech
Steven Jay Adelman
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of ATE177111T1 publication Critical patent/ATE177111T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT95915579T 1994-04-08 1995-04-06 Doppelbindungs-isomer von equilin erhalten durch säure-isomerisierung ATE177111T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/224,849 US5395831A (en) 1994-04-08 1994-04-08 Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone

Publications (1)

Publication Number Publication Date
ATE177111T1 true ATE177111T1 (de) 1999-03-15

Family

ID=22842497

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95915579T ATE177111T1 (de) 1994-04-08 1995-04-06 Doppelbindungs-isomer von equilin erhalten durch säure-isomerisierung

Country Status (18)

Country Link
US (3) US5395831A (de)
EP (1) EP0754190B1 (de)
JP (1) JPH09511748A (de)
KR (1) KR970702291A (de)
CN (1) CN1149298A (de)
AT (1) ATE177111T1 (de)
AU (1) AU688029B2 (de)
CA (1) CA2186486A1 (de)
DE (1) DE69508068T2 (de)
DK (1) DK0754190T3 (de)
ES (1) ES2128051T3 (de)
GR (1) GR3030185T3 (de)
HU (1) HUT76338A (de)
IL (1) IL113178A (de)
NZ (1) NZ283951A (de)
TW (1) TW314468B (de)
WO (1) WO1995027724A1 (de)
ZA (1) ZA952771B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone
EP0761679A1 (de) * 1995-08-30 1997-03-12 Eli Lilly And Company N-Butylsulphonatester von Oestrogenen
IL119468A (en) * 1995-11-06 2000-02-29 Akzo Nobel Nv Method of isomerisation of equilin or derivatives thereof
US5998639A (en) * 1995-11-06 1999-12-07 Akzo Nobel, N.V. Sulfatation of estrogen mixtures
AU703814B2 (en) * 1995-12-04 1999-04-01 Wyeth Antioxidant
ID18256A (id) * 1996-09-16 1998-03-19 American Home Prod Penggunaan dari 8,9-dehidro estron sebagai estrogen dengan hasil netral pada tingkat prolaktin
IL124213A (en) * 1997-05-02 2004-12-15 Akzo Nobel Nv Sulfation of estrogen mixtures
DE19723794A1 (de) * 1997-06-06 1998-12-10 Jenapharm Gmbh Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität
US5866561A (en) * 1997-08-21 1999-02-02 Scimed Life Systems, Inc. Local delivery of estrogen for angiogenesis
GB9817623D0 (en) * 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
ATE361310T1 (de) 2000-11-03 2007-05-15 Univ Washington Östronderivate mit zellschützender wirkung
WO2002040032A2 (en) * 2000-11-17 2002-05-23 Washington University Cytoprotective estrogen derivatives
US20030158432A1 (en) * 2002-01-08 2003-08-21 Leonard Thomas W. Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex
US6855735B2 (en) 2002-03-20 2005-02-15 Temple University Of The Commonwealth System Of Higher Education Ketamine treatment of restless legs syndrome
US7186707B2 (en) * 2002-04-01 2007-03-06 University Of Florida Prodrugs for use as ophthalmic agents
US7300926B2 (en) * 2002-04-01 2007-11-27 University Of Florida Research Foundation, Inc. Steroidal quinols and their use for estrogen replacement therapy
PT1490392E (pt) * 2002-04-01 2007-04-30 Univ Florida Quinóis esteroidais como pró-fármacos de antioxidantes
US20070213310A1 (en) * 2002-04-01 2007-09-13 Laszlo Prokai Prodrugs for Use as Ophthalmic Agents

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE205169C (de) *
US3394153A (en) * 1965-08-18 1968-07-23 Merck & Co Inc Process for the preparation of d, 1-8-dehydroestrone, and intermediates obtained therefrom
US3391170A (en) * 1965-09-21 1968-07-02 Smith 13-alkylogona-1, 3, 5 (10), 9 (11)-tetraenes
US3385872A (en) * 1966-08-29 1968-05-28 Syntex Corp Process for the preparation of 3-hydroxy-19-nor-delta1, 3, 5(10), 9(11)-tetraene steroids
US3471528A (en) * 1968-02-21 1969-10-07 Lilly Co Eli Method for producing delta**9(11) unsaturation in estrone and related compound
US3542819A (en) * 1968-06-11 1970-11-24 American Home Prod Process for preparing 8-isoestrone
US3649621A (en) * 1969-12-19 1972-03-14 American Home Prod Novel 3-cyclopentyl ethers of 13-alkylgon-poly-enes
US3689512A (en) * 1970-10-06 1972-09-05 American Home Prod Novel 3-etherified-1,3,5(10)-triene-steroids and process thereof
DE3014120A1 (de) * 1980-04-12 1981-10-29 Hoechst Ag, 6000 Frankfurt Verfahren zur synthese von oestron bzw. oestronderivaten
DD205169A1 (de) * 1982-05-26 1983-12-21 Adw Ddr Verfahren zur herstellung von 9(11)-dehydro-oestra-1,3,5(10)-trienen
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone

Also Published As

Publication number Publication date
TW314468B (de) 1997-09-01
US5395831A (en) 1995-03-07
IL113178A (en) 2000-07-26
DK0754190T3 (da) 1999-09-27
KR970702291A (ko) 1997-05-13
AU688029B2 (en) 1998-03-05
AU2242195A (en) 1995-10-30
IL113178A0 (en) 1995-06-29
US5552395A (en) 1996-09-03
CA2186486A1 (en) 1995-10-19
NZ283951A (en) 1998-07-28
ES2128051T3 (es) 1999-05-01
HUT76338A (en) 1997-08-28
EP0754190B1 (de) 1999-03-03
GR3030185T3 (en) 1999-08-31
DE69508068T2 (de) 1999-10-28
DE69508068D1 (de) 1999-04-08
CN1149298A (zh) 1997-05-07
HU9602755D0 (en) 1996-11-28
JPH09511748A (ja) 1997-11-25
WO1995027724A1 (en) 1995-10-19
EP0754190A1 (de) 1997-01-22
ZA952771B (en) 1996-10-04
US5496814A (en) 1996-03-05

Similar Documents

Publication Publication Date Title
ATE177111T1 (de) Doppelbindungs-isomer von equilin erhalten durch säure-isomerisierung
RU94027577A (ru) Производные 1-бензолсульфонил-1,3-дигидро-2н-бензимидазол-2-она, способ их получения, содержащая их фармацевтическая композиция
ES2017838A6 (es) Un procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
IS4695A (is) (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem sýklóoxýgenasa-2 tálmar
NO20004615L (no) FremgangsmÕte for fremstilling av linolsyre, og preparater inneholdende denne
EP0339237A3 (de) Phenol-substituierte Gem-Diphosphonat-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE59407237D1 (de) Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems
CA2234642A1 (en) 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
EP1065203A3 (de) Heterocyclische Verbindungen als Refinoid-Rezeptorantagonisten
DE69233074D1 (de) Verfahren zur Herstellung von 1-alpha-24-dihydroxy-Vitamin D2
CA2123232A1 (fr) Compositions pharmaceutiques a base d'ebastine ou de ses analogues
WO1994005630B1 (en) 1α,24(S)-DIHYDROXY VITAMIN D2, ITS FORMATION AND USE
NO962285D0 (no) N-substituerte azabicykloheptan-derivater anvendt for eksempel som neuroleptika
PL328225A1 (en) Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors
ATE127465T1 (de) Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen.
IT8220757A0 (it) Sale di magnesio dell'acido chenodesossicolico e dell'acido ursodesossicolico, processo per lasua preparazione e composizioni terapeutiche che lo contengono come principio attivo.
AU1214292A (en) Indane derivatives
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
DE69426495D1 (de) Weizensprossensaft enthaltendes stabiles präparat und verfahren zu seiner herstellung
HUT73562A (en) Thiocarbamoyl-pyrazole derivatives, keto-carboxylic acid ester intermediates thereof, preparations thereof, using the pyrazole derivatives and microbicide compositions containing these compounds
UY23885A1 (es) Composiciones pesticidas que contienen derivados de acido fenilacetico y procedimiento para su preparacion

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee